XTalks

NOVEMBER 2, 2023

The clinical research landscape is witnessing a significant transformation. With rapid technological advancements, evolving regulatory environments and a growing need for collaborative knowledge exchange, it’s imperative for professionals within this space to stay abreast of the latest trends and insights. Xtalks has taken a monumental step to cater to this need by unveiling its pioneering publication, the Xtalks Clinical Edge magazine.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Bio Pharma Dive

NOVEMBER 2, 2023

The rival companies reported strong quarterly sales growth for their latest products, which could face off as weight loss treatments next year.

Sales 305

Sales Production Drugs 305

Pharmaceutical Technology

NOVEMBER 2, 2023

Memo’s fast track-designated candidate is currently in a Phase II trial for BKV infection, with a data readout expected in 2024.

Trials 278

Trials 278

Bio Pharma Dive

NOVEMBER 2, 2023

The gene therapy company will move headquarters and reduce its workforce by 40%, while seeking partners for its Fabry and cell therapy research.

Gene Therapy 289

Gene Therapy Gene Research 289

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

NOVEMBER 2, 2023

The UK MHRA authorises Pfizer’s Litfulo (ritlecitinib), to treat severe alopecia areata in people aged 12 years and above.

246

246

Bio Pharma Dive

NOVEMBER 2, 2023

The rare disease drug developer is turning to former Genentech head Alexander Hardy as the launch of its Roctavian gene therapy stumbles.

Gene Therapy 278

Gene Therapy Gene Development Drugs 278

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 2, 2023

If you have hay fever, you’ve probably been sneezing a lot lately. Sneezing is universal but also quite unique to each of us. It is a protective reflex action outside our conscious control, to remove irritants from inside our nose.

Clinical Trials 236

Clinical Trials Clinical Trials Clinical Research Trials 236

Bio Pharma Dive

NOVEMBER 2, 2023

Stock selloffs across the medical device sector have erased hundreds of billions of dollars in market value. But medtech executives argue GLP-1 drug demand will complement, not cannibalize, their sales.

Drugs 173

Drugs Sales Marketing 173

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 2, 2023

India is strengthening its scope in contract manufacturing as the global customers commend the strengths and dependability of its pharma and biotech sectors.

Contract Manufacturing 186

Contract Manufacturing Manufacturing Pharmacy Clinical Trials 186

Pharmaceutical Technology

NOVEMBER 2, 2023

The companies will jointly develop up to five antibody-drug conjugates for treating cancer, with a focus on SMARCA degraders.

Antibody 162

Antibody Development Drugs 162

Advertisement

Clinical Supply

Pharma Times

NOVEMBER 2, 2023

The NHS has already delivered over 20 million winter vaccines this year - News - PharmaTimes

Vaccine 139

Vaccine Vaccination 139

Fierce Pharma

NOVEMBER 2, 2023

The days of booming COVID-19 vaccine sales, which sent Moderna into the ranks of pharma's top companies, have | The company is focusing on scaling back its manufacturing efforts to cope with the lack of COVID-19 vaccine demand.

Sales 131

Sales Manufacturing Vaccine Vaccination 131

Pharma Times

NOVEMBER 2, 2023

The new AI model could potentially be applied to other cancers - News - PharmaTimes

133

133

Pharmaceutical Technology

NOVEMBER 2, 2023

As per the latest restructuring plan, Sangamo will advance its programs using AAV capsid delivery, Nav1.7 program, and Prion therapies.

Production 130

Production 130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Fierce Pharma

NOVEMBER 2, 2023

The third quarter marked a momentous one for Sarepta Therapeutics, bringing the long-anticipated launch of its Duchenne muscular dystrophy (DMD) gene therapy Elevidys. | Even before a potential label expansion, the gene therapy Elevidys has raked in around $69 million since its launch. Earlier this week, the company said that a pivotal trial on the medicine failed to reach its primary endpoint.

Gene Therapy 119

Gene Therapy Gene Sales Medicine 119

Pharmaceutical Technology

NOVEMBER 2, 2023

Revenues saw a decline of 32% to $3.4bn from $5bn in the same quarter of the previous year, but the company is projecting a profit in 2024.

130

130

Fierce Pharma

NOVEMBER 2, 2023

Supply problems for Eli Lilly’s diabetes med Mounjaro were no secret. But strong demand continues to push sales of the GLP-1/GIP agonist to new highs ahead of an FDA decision on weight loss. | As strong demand continues to push Mounjaro sales to new highs, Eli Lilly CEO David Ricks said the company is "not done with" manufacturing expansions.

Manufacturing 116

Manufacturing Sales 116

Pharmaceutical Technology

NOVEMBER 2, 2023

Aldeyra Therapeutics and AbbVie have signed an agreement for the development, manufacture and commercialisation of reproxalap.

Development 130

Development Manufacturing 130

Advertisement

Clinical Supply

Fierce Pharma

NOVEMBER 2, 2023

Ever since Novo Nordisk won FDA approval for its GLP-1 weight-loss med Wegovy more than 2 years ago, analysts and investors have been keeping a close eye on the blockbuster drug launch. | Ever since Novo Nordisk won FDA approval for its GLP-1 weight-loss med Wegovy more than 2 years ago, analysts and investors have been keeping a close eye on the blockbuster drug launch.

FDA Approval 115

FDA Approval Sales Manufacturing Drugs 115

Pharmaceutical Technology

NOVEMBER 2, 2023

GSK has reported a total operating profit of £1.

130

130

pharmaphorum

NOVEMBER 2, 2023

12 Questions with Jenny Reid-Young Mike.

114

114

Pharmaceutical Technology

NOVEMBER 2, 2023

While things may have slowed down a little since the rapid approvals of the COVID-19 vaccines, the excitement around RNA-LNP is still going strong. We spoke to nanomedicine experts at Precision NanoSystems to understand the process development and manufacturing challenges that lie ahead of companies approaching the clinical phase, and how the right partnerships can work wonders.

RNA 130

RNA Manufacturing Vaccine Vaccination 130

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

pharmaphorum

NOVEMBER 2, 2023

Sangamo sheds staff once again in another retreat Phil.

111

111

Pharmaceutical Technology

NOVEMBER 2, 2023

The company terminated the RT-101 programme while pausing the development of the RT-105 and RT-110 compounds.

Drugs 130

Drugs Development 130

Fierce Pharma

NOVEMBER 2, 2023

In a span of three days, Phathom Pharmaceuticals has scored two green lights from the FDA for its first-in-class heartburn drug Voquezna (vonoprazan). | In a span of three days, Phathom Pharmaceuticals has scored two green lights from the FDA for its first-in-class heartburn drug Voquezna. The first came on Monday when the regulator signed off on Phathom’s reformulation of Voquezna to treat Helicobacter pylori infection.

FDA Approval 111

FDA Approval Regulation Drugs 111

pharmaphorum

NOVEMBER 2, 2023

Novo Nordisk shrugs off supply issues with record sales Phil.

Sales 105

Sales 105

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Fierce Pharma

NOVEMBER 2, 2023

Roche’s surge in sales for its long-acting macular degeneration drug Vabysmo showed that patients in the market are open to switching to another treatment. | After gaining FDA approval for its high-dose Eylea, Regeneron racked up $43 million in sales in the U.S. over the final six weeks of the third quarter for the new formulation. Regeneron and partner Bayer are battling Roche's Vabysmo in the treatment of multiple eye diseases.

FDA Approval 108

FDA Approval Sales Marketing Drugs 108

pharmaphorum

NOVEMBER 2, 2023

Samay’s AI-enabled wearable ‘can diagnose COPD’ Phil.

105

105

Rethinking Clinical Trials

NOVEMBER 2, 2023

The NIH Pragmatic Trials Collaboratory has launched an enhanced training section of rethinkingclinicialtrials.org that includes a new series of video learning modules and reorganized and refreshed pragmatic clinical trials training resources. The new training section features a series of 8 self-paced, guided video modules on topics that cover every phase of a pragmatic clinical trial.

Trials 100

Trials Clinical Trials Clinical Trials Research 100

pharmaphorum

NOVEMBER 2, 2023

Change at the top at BioMarin as CEO Bienaimé steps down Phil.

105

105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials